Search

Your search keyword '"Clynes, Raphael"' showing total 317 results

Search Constraints

Start Over You searched for: Author "Clynes, Raphael" Remove constraint Author: "Clynes, Raphael"
317 results on '"Clynes, Raphael"'

Search Results

53. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata

56. Novel technologies and emerging biomarkers for personalized cancer immunotherapy

57. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

58. Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.

59. FcγRIIB prevents Inflammatory Type I Interferon Production from pDCs during a Viral Memory Response

60. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

64. Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

66. Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation

68. Novel technologies and emerging biomarkers for personalized cancer immunotherapy

69. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci

70. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci

71. Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells1

74. Associations of HER2-specific immunity with survival during treatment with trastuzumab and chemotherapy in breast cancer.

77. LBP34

78. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci

79. RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1

80. P015

84. 1011-LBP

87. 21-P

89. Combination trastuzumab and chemotherapy to induce immunity to multiple tumor antigens in patients with HER2-positive metastatic breast cancer: NCCTG (Alliance) studies N0337 and N98-32-52.

90. Generation of adaptive HER2-specific immunity in HER2 breast cancer patients by addition of trastuzumab to chemotherapy in the adjuvant setting: NCCTG (Alliance) study N9831.

93. Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

99. BISPHENOL-A AND T REGULATORY CELL COUNTS IN AN INNER-CITY BIRTH COHORT

100. Correction: Therapeutic Targeting of Syk in Autoimmune Diabetes

Catalog

Books, media, physical & digital resources